drugset / Trial / NCT02847143

Ocytocine and Cerebral Activation in Relation With Attachement

NCT02847143 ↗

Phase 2 Completed 100 enrolled Centre Hospitalier Universitaire de Besancon
RandomizedCrossoverQuadruple-blindTreatment

Summary

The study aims to characterize the cerebral activation modifications related to nasal oxytocin administration during vizualisation of distress images in population of healthy people with different attachement styles.

Timeline

Start
2015-04-09
Primary completion
2018-04-27
Completion
2018-04-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide — Intranasal

Indications

No indication recorded.